Shafique Virani is Chief Business Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 136,748 shares of RXRX, which is worth approximately $1.07 Million. The most recent transaction as insider was on Feb 04, 2022, when has been sold 1,114 shares (Class A Common Stock) at a price of $11.4 per share, resulting in proceeds of $12,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
0% 3M change
2.57% 12M change
Total Value Held $1.07 Million

Shafique Virani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 04 2022
SELL
Payment of exercise price or tax liability
$12,700 $11.4 p/Share
1,114 Reduced 1.05%
105,256 Class A Common Stock
Feb 04 2022
BUY
Grant, award, or other acquisition
-
42,943 Added 28.76%
106,370 Class A Common Stock
Jun 02 2021
BUY
Exercise of conversion of derivative security
$100,000 $2.22 p/Share
45,045 Added 41.67%
63,045 Class A Common Stock
Apr 20 2021
SELL
Other acquisition or disposition
-
18,000 Reduced 100.0%
0 Common Stock
Apr 20 2021
BUY
Other acquisition or disposition
-
18,000 Added 50.0%
18,000 Class A Common Stock
SV

Shafique Virani

Chief Business Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX